Post job

TriVascular main competitors are Endologix, Kyphon, and Freudenberg Medical.

Competitor Summary. See how TriVascular compares to its main competitors:

  • W. L. Gore & Associates has the most employees (10,500).
  • Employees at Endologix earn more than most of the competitors, with an average yearly salary of $71,608.
Work at TriVascular?
Share your experience

TriVascular vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1998
4.4
Santa Rosa, CA1$31.8M200
1992
4.7
Irvine, CA2$95.3M488
1998
4.5
Redwood City, CA1$83.8M202
1994
4.1
Sunnyvale, CA1-3,000
2006
4.1
Milford, CT1$11.7M25
1995
4.2
Austin, TX1$378.0M1,000
1989
4.7
Saint Paul, MN3$236.2M780
1997
3.8
Redwood City, CA1$3.4M50
2004
3.9
San Francisco, CA1$39.6M161
-
3.6
Andover, MA1-100
Lombard Medical
1994
3.7
Irvine, CA1$540,0003
1958
4.4
Newark, DE9$3.2B10,500
1970
4.7
Clarence, NY4$290.0M500
1984
4.3
Carpinteria, CA2$300.0M400

Rate TriVascular's competitiveness in the market.

Zippia waving zebra

TriVascular salaries vs competitors

Among TriVascular competitors, employees at Endologix earn the most with an average yearly salary of $71,608.

Compare TriVascular salaries vs competitors

CompanyAverage salaryHourly salarySalary score
TriVascular
$62,029$29.82-
Endologix
$71,608$34.43-
Pulmonx
$64,191$30.86-
Kyphon
$71,077$34.17-
SurgiQuest
$45,488$21.87-
Arthrocare
$64,919$31.21-

Compare TriVascular job title salaries vs competitors

CompanyHighest salaryHourly salary
TriVascular
$52,933$25.45
Kyphon
$53,491$25.72
Cardiovascular Systems
$47,374$22.78
Arthrocare
$46,429$22.32
Invuity
$45,834$22.04
W. L. Gore & Associates
$44,887$21.58
Endologix
$44,740$21.51
Greatbatch Medical
$44,419$21.36
Lombard Medical
$44,337$21.32
Dextera Surgical
$43,899$21.11
SurgiQuest
$43,807$21.06
Pulmonx
$43,773$21.04
Freudenberg Medical
$43,748$21.03
Diomed Holdings, Inc
$43,637$20.98

Do you work at TriVascular?

Is TriVascular able to compete effectively with similar companies?

TriVascular jobs

TriVascular demographics vs competitors

Compare gender at TriVascular vs competitors

Job titleMaleFemale
Cardiovascular Systems43%57%
TriVascular51%49%
Endologix55%45%
W. L. Gore & Associates62%38%
Greatbatch Medical63%37%
Invuity76%24%

Compare race at TriVascular vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
55%21%7%11%6%
9.1
61%14%9%13%3%
9.7
37%21%5%32%5%
9.3
46%13%10%26%5%
7.1
59%11%9%17%4%
9.3
59%16%13%8%4%
9.7

TriVascular and similar companies CEOs

CEOBio

Mr. Ward has been a member of our Board of Directors since 2013 and has served as Chairman since November 2014. Mr. Ward served as our Interim President and Chief Executive Officer commencing in November 2015. In August 2016, Mr. Ward was appointed President and Chief Executive Officer. Since 2013, Mr. Ward has been one of the Managing Directors at SightLine Partners. Following his appointment as our President and Chief Executive Officer, Mr. Ward continues to be a Managing Director of Sightline Opportunity Management Fund II, LLC, and may provide limited advisory and consulting services to Sightline Partners in this capacity.

Julian N Nikolchev
Dextera Surgical

John Onopchenko
Endologix

John Onopchenko is a Board Member at Synecor, Board Member at Endologix Inc, and Chief Executive Officer at Endologix Inc. He has worked as Chief Operating Officer at VOLCANO CO., LTD.; Chief Operating Officer at Endologix Inc; and Exec VP:Strategy at VOLCANO CO., LTD.. John works or has worked as VP:Venture Investments at Johnson & Johnson Innovation - Jjdc Inc, Managing Director/Gen Partner at Synergy Life Sciences Partners, and MEMBER at FINRA. He studied at University of Chicago Booth School of Business and Ursinus College.

Scott Flora
Invuity

Scott Flora has more than 40 years of healthcare experience in surgical devices and is currently serving as Board Chair for Palliare Ltd and New View Surgical. He is also on the Board of Conventus/Flower Orthopaedics. Prior to that Scott held the following leadership roles, Interim President and CEO of Invuity, Executive Director of Conventus Orthopaedics, President and CEO of OmniGuide Surgical, President of Covidien's Surgical Device Group ,President Smith& Nephew Orthopedic Reconstruction, General Manager Smith&Nephew Trauma , Sr. V.P. Sales US and Europe, Global V.P. Sales & Marketing Ioptex Research. Scott has also served on three public company boards, Invuity, MAKO Surgical and Tengion. Scotts skills have been demonstrated in:Building Effective TeamsInnovation ManagementResults OrientedStrategic AgilityBuilding a Strong Vision supported by ValuesGlobal LeadershipCommercial ExecutionGovernance

Joseph William Dziedzic
Greatbatch Medical

Richard Mott (Rich)
Kyphon

Richard 'Rich' Mott is a Chairman at Conventus Orthopaedics Inc, President/CEO at Kyphon, and Board Member at Vertiflex. He has worked as Board Member at Alfred University, Board Member at Conventus Orthopaedics Inc, and VP/General Manager at Greatbatch Scientific. Richard attended Alfred University and Harvard University.

Olivier Bohuon
Arthrocare

Glendon E. French
Pulmonx

Glendon French is a President/CEO at Pulmonx and Board Member at Pulmonx. He has worked as Board Member at Cardiac Pathways Corp, Board Member at Asthmatx Inc, and Chief Executive Officer/Director at ApniCure Inc. Glendon works or has worked as TRUSTEE at The Oliver Fund. He attended DARTMOUTH COLLEGE and The Wharton School.

TriVascular competitors FAQs

Search for jobs